生物防禦市場規模、佔有率、成長分析、按類型、應用、按地區 - 產業預測，2024-2031 年

Biodefense Market Size, Share, Growth Analysis, By Type (Anthrax, Smallpox), By Application (Hospitals and clinics, Ambulatory care centers), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球生物防禦市場規模為152.2億美元，從2023年的159.9億美元成長到2031年的236.7億美元，預測期（2024-2031）預計複合年成長率為5.03%。

由於生技藥品的威脅不斷增加以及對有效準備和應對策略的需求不斷成長，全球生物防禦市場近年來經歷了顯著的成長和轉型。生物防禦涵蓋廣泛的活動和技術，旨在應對與生物恐怖主義、流行病和其他生物緊急情況相關的風險。這個市場包括疫苗、治療、檢測和診斷以及防護工具等各個領域。對生物防禦解決方案的需求不斷成長，反映出人們越來越意識到生物攻擊和爆發的潛在破壞性影響，並推動世界各國政府大力投資生物防禦能力。基因組學、合成生物學和資料分析等技術的進步正在推動創新和複雜的生物防禦產品的開發。政府、國防機構和私人組織之間的合作也正在推動全面的生物防禦戰略和市場成長。然而，監管障礙、高昂的研發成本以及生物防禦威脅的複雜性等挑戰構成了重大障礙。儘管存在這些挑戰，但隨著各國優先考慮並投資加強生物防禦措施，市場預計將繼續擴大。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

XOMA Corporation
Altimmune Inc.
Emergent Biosolutions Inc.
Dynavax Technologies Corporation
SIGA Technologies
Elusys Therapeutics Inc.
Ichor Medical Systems
Dynport Vaccine Company
Cleveland Biolabs
Bavarian Nordic
Ology Bioservices
Alnylam Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc.
PharmAthene Inc.
Profectus Biosciences Inc.
NanoViricides Inc.
Takeda Pharmaceutical Company Limited
Sanofi Pasteur
GlaxoSmithKline

簡介目錄

Product Code: SQMIG35H2213

Global Biodefense Market size was valued at USD 15.22 billion in 2022 and is poised to grow from USD 15.99 billion in 2023 to USD 23.67 billion by 2031, growing at a CAGR of 5.03% during the forecast period (2024-2031).

The global biodefense market has experienced notable growth and transformation recently, driven by escalating threats from biological agents and the increasing need for effective preparedness and response strategies. Biodefense encompasses a broad array of activities and technologies designed to address risks related to bioterrorism, pandemics, and other biological emergencies. This market includes various sectors such as vaccines, therapeutics, detection and diagnostics, and protective equipment. The rising demand for biodefense solutions reflects heightened awareness of the potentially devastating impacts of biological attacks and outbreaks, leading governments worldwide to invest heavily in biodefense capabilities. Technological advancements, including genomics, synthetic biology, and data analytics, are enhancing the development of innovative and sophisticated biodefense products. Collaborations between governments, defense agencies, and private sector organizations are also advancing comprehensive biodefense strategies and market growth. However, challenges such as regulatory obstacles, high R&D costs, and the complex nature of biodefense threats present significant hurdles. Despite these challenges, the market is expected to continue expanding as countries prioritize and invest in strengthening their biodefense measures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segmental Analysis

Global Biodefense Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others. Based on Application, the market is segmented into Hospitals and clinics, Ambulatory care centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Biodefense Market

A major driver of the global biodefense market is the growing awareness of the severe and potentially catastrophic impacts of biological threats. In response, governments, defense agencies, and healthcare organizations around the world are making substantial investments in biodefense measures. These efforts are aimed at addressing and mitigating the risks associated with bioterrorism, pandemics, and other biological emergencies, highlighting the urgent need for enhanced preparedness and response capabilities.

Restraints in the Global Biodefense Market

A significant constraint for the Global Biodefense Market is the substantial financial burden associated with the research and development of biodefense solutions. The creation of effective vaccines, therapeutics, and detection systems demands considerable investment in areas such as research, clinical trials, and regulatory compliance. This high cost, compounded by the intricate nature of biodefense threats, makes it challenging to develop cost-effective solutions and impedes overall market growth. The financial demands and complex challenges associated with biodefense R&D can limit the pace of innovation and market expansion, further restricting progress in this critical field.

Market Trends of the Global Biodefense Market

A significant trend in the global biodefense market is the heightened emphasis on advancing diagnostic technologies. This trend reflects a growing need for rapid and precise detection of biological agents, which is crucial for early intervention and effective response during biodefense incidents. The development of innovative diagnostic tools, including point-of-care testing devices and molecular diagnostics, is central to this focus. These technologies aim to enhance both the speed and accuracy of identifying potential biological threats. By improving surveillance systems and overall preparedness, these advancements are expected to bolster response capabilities in biodefense scenarios.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Landscape
Patent Analysis
Pipeline Product Analysis
PESTEL Analysis

Biodefense Market, By Type

Market Overview
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others

Biodefense Market, By Application

Market Overview
Hospitals and clinics
Ambulatory care centres
Others

Biodefense Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

XOMA Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altimmune Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Emergent Biosolutions Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynavax Technologies Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIGA Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elusys Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ichor Medical Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynport Vaccine Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bavarian Nordic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ology Bioservices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alnylam Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioCryst Pharmaceuticals Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PharmAthene Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Profectus Biosciences Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NanoViricides Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi Pasteur
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments